Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices
Contract Research & Services
Contract Research
Return to: PBR Home | Contract Research & Services | Contract Research

Contract Research

OnCore, Blumberg enter exclusive HBV research collaboration By PBR Staff Writer
US-based OnCore Biopharma has entered into a hepatitis B virus (HBV) and liver cancer research collaboration with the Baruch S. Blumberg Institute (Blumberg), the research center of the Hepatitis B Foundation.
Contract Research & Services > Contract Research > News
CDISC and TransCelerate announce availability of new standards for diabetes and cardiovascular disease The Clinical Data Interchange Standards Consortium and TransCelerate BioPharma are pleased to announce the availability of therapeutic area (TA) standards for diabetes and cardiovascular (CV) disease areas through the Coalition for Accelerating Standards and Therapies (CFAST), a joint initiative of CDISC and the Critical Path Institute (C-Path).
Contract Research & Services > Contract Research > News Alliance for Children’s Therapeutics to expand pediatric research to MS, IBD and asthma The Alliance for Children’s Therapeutics announced it will expand its pediatric research into multiple sclerosis (MS), inflammatory bowel disease (IBD), and asthma.
Contract Research & Services > Contract Research > News
See more Contract Research news

Latest Contract Research News and Insight

View all Contract Research news or find news targeted to your interests
Alliance for Children’s Therapeutics to expand pediatric research to MS, IBD and asthma
The Alliance for Children’s Therapeutics announced it will expand its pediatric research into multiple sclerosis (MS), inflammatory bowel disease (IBD), and asthma.
Contract Research & Services > Contract Research > News
Boehringer, WellPoint and HealthCore start new multi-year research collaboration
By PBR Staff Writer
Boehringer Ingelheim Pharmaceuticals (BIPI), WellPoint and HealthCore are starting a research project to identify gaps in non-valvular atrial fibrillation research, development and treatment.
Contract Research & Services > Contract Research > News
Bristol Myers reports positive Phase III trial results of melanoma drug Opdivo
By PBR Staff Writer
Bristol Myers Squibb (BMS) has reported positive results from a Phase III trial (CheckMate -066) comparing an investigational PD-1 immune checkpoint inhibitor, Opdivo, to the chemotherapy dacarbazine (DTIC) in patients with treatment naïve BRAF wild-type advanced melanoma.
Contract Research & Services > Contract Research > News
Woodley Equipment Company Announces the Appointment of Monika Hrdinkova
Woodley Equipment Company is pleased to announce the appointment of Monika Hrdinkova as office administrator working for our clinical trials division at our Hopkinton office near Boston, Massachusetts, US. Monika has extensive business management, customer service and logistics experience and Monika’s appointment will further strengthen the clinical trials customer service team.
Contract Research & Services > Contract Research > Press Releases
GSK seeks proposals for non-communicable diseases research in Africa
By PBR Staff Writer
British drugmaker GlaxoSmithKline (GSK) is seeking proposals for its Africa non-communicable diseases (NCDs) Open Lab, to support the scientific research into NCDs in the continent.
Contract Research & Services > Contract Research > News
Dynasil's RMD subsidiary gets $3.5m in technology development grants from NIH
Dynasil Corporation of America announced that its contract research subsidiary, RMD, has received three grants totaling $3.5m under the National Institute of Health's Small Business Innovation Research (SBIR) Program.
Contract Research & Services > Contract Research > News
Medgenics, CHOP enter rare and orphan disease research collaboration
By PBR Staff Writer
Medgenics has entered into a major research collaboration with The Children's Hospital of Philadelphia (CHOP) focused on pediatric rare and orphan genetic diseases.
Contract Research & Services > Contract Research > News
AVEO, Ophthotechr enter research and option deal for tivozanib to treat ocular diseases
By PBR Staff Writer
US-based biopharmaceutical firm AVEO Oncology has entered into a research and exclusive option agreement with Ophthotech for vascular endothelial growth factor (VEGF) tyrosine kinase inhibitor, tivozanib, to treat ocular diseases.
Contract Research & Services > Contract Research > News
The Value of Biobetters
| By PRA Health Sciences
The market of biologics is growing at a nearly twice the rate of pharma as a whole. Biologics are expected to account for approximately 17% of total global spending on medicines by 2016, and reach an overall market value of $200 billion to $210 billion in 2016, up from $157 billion in 2011.Seven of the top 10 global medicines by spending will be a biologic within the next 5 years.
Contract Research & Services > Contract Research > White Papers
Hybrigenics Services - Protein Interactions Expert
Who else knows your protein better than you? Who else knows proteins interactions better than us?
Contract Research & Services > Contract Research > Suppliers
View all Contract Research news or find news targeted to your interests

Buy the latest industry research online today!
Shire Plc : Pharmaceuticals & Healthcare - Company Profile, SWOT & Financial Report 03 October 2013 This report is a crucial resource for industry executives and anyone looking to access key information about "Shire Plc" The report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format. ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report. Buy online from $250